Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-29

Clinical Trial Update: Comparison of Aerosol Delivery of Infasurf to Usual Care in Spontaneously Breathing RDS Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing aerosol delivery of Infasurf to usual care in spontaneously breathing patients with Respiratory Distress Syndrome has completed enroll…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INFASURF (calfactant)

Snippet

Sponsor: ONY | Conditions: Respiratory Distress Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2024-05-29